enalaprilat

Generic: enalaprilat

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name enalaprilat
Generic Name enalaprilat
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

enalaprilat 1.25 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1477
Product ID 51662-1477_12044a95-d04f-2681-e063-6394a90af8cc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078687
Listing Expiration 2026-12-31
Marketing Start 2020-02-01

Pharmacologic Class

Classes
angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa] decreased blood pressure [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621477
Hyphenated Format 51662-1477

Supplemental Identifiers

RxCUI
1729200
UNII
GV0O7ES0R3

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name enalaprilat (source: ndc)
Generic Name enalaprilat (source: ndc)
Application Number ANDA078687 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 1.25 mg/mL
source: ndc
Packaging
  • 1 mL in 1 VIAL (51662-1477-1)
source: ndc

Packages (1)

51662-1477-1 1 mL in 1 VIAL (51662-1477-1)

Ingredients (1)

enalaprilat (1.25 mg/mL)

Linked Drug Pages (1)

ENALAPRILAT ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "12044a95-d04f-2681-e063-6394a90af8cc", "openfda": {"unii": ["GV0O7ES0R3"], "rxcui": ["1729200"], "spl_set_id": ["9d88f915-13dd-5463-e053-2a95a90a09bf"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL (51662-1477-1)", "package_ndc": "51662-1477-1", "marketing_start_date": "20200201"}], "brand_name": "ENALAPRILAT", "product_id": "51662-1477_12044a95-d04f-2681-e063-6394a90af8cc", "dosage_form": "INJECTION", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]"], "product_ndc": "51662-1477", "generic_name": "ENALAPRILAT", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ENALAPRILAT", "active_ingredients": [{"name": "ENALAPRILAT", "strength": "1.25 mg/mL"}], "application_number": "ANDA078687", "marketing_category": "ANDA", "marketing_start_date": "20200201", "listing_expiration_date": "20261231"}